Acorda Therapeutics
ACOR
#10104
Rank
S$1.1 M
Marketcap
$0.89
Share price
0.00%
Change (1 day)
-95.62%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -S$0.36 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are S$0.11 Billion. In 2023 the company made an earning of -S$0.36 Billion a decrease over its 2022 earnings that were of -S$7.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.36 Billion1.23%
2023 -S$0.36 Billion4848.63%
2022 -S$7.19 Million-93.25%
2021 -S$0.11 Billion2.52%
2020 -S$0.11 Billion-69.45%
2019 -S$0.34 Billion-700.62%
2018 S$56.52 M-118.02%
2017 -S$0.32 Billion805.99%
2016 -S$34.63 Million-173.88%
2015 S$46.86 M-6.58%
2014 S$50.17 M20.19%
2013 S$41.74 M18.7%
2012 S$35.16 M-26.54%
2011 S$47.87 M
2009 -S$0.11 Billion10.65%
2008 -S$98.8 Million86.17%
2007 -S$53.07 Million68.1%
2006 -S$31.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$28.86 M-107.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.52 B-244.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.12 Billion-68.58%๐Ÿ‡ฉ๐Ÿ‡ช Germany
S$83.7 M-122.89%๐Ÿ‡บ๐Ÿ‡ธ USA